311 related articles for article (PubMed ID: 16832773)
1. [Symptomatic treatment of migraine with zolmitriptan: experience with 82 patients].
Pascual J; Navarro A; Caminero AB; Jurado C; Díaz-Insa S; Huerta M
Neurologia; 2006 May; 21(4):188-91. PubMed ID: 16832773
[TBL] [Abstract][Full Text] [Related]
2. [Experience with intranasal zolmitriptan in cluster headache].
Pascual J; Navarro A; Caminero AB; Jurado C
Neurologia; 2006 Apr; 21(3):131-4. PubMed ID: 16575626
[TBL] [Abstract][Full Text] [Related]
3. Patient preference for triptan formulations: a prospective study with zolmitriptan.
Dowson A; Bundy M; Salt R; Kilminster S
Headache; 2007 Sep; 47(8):1144-51. PubMed ID: 17883519
[TBL] [Abstract][Full Text] [Related]
4. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial.
Dowson AJ; Charlesworth BR; Green J; Färkkilä M; Diener HC; Hansen SB; Gawel M;
Headache; 2005 Jan; 45(1):17-24. PubMed ID: 15663608
[TBL] [Abstract][Full Text] [Related]
5. Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet.
Dowson AJ; Charlesworth BR
Int J Clin Pract; 2003 Sep; 57(7):573-6. PubMed ID: 14529055
[TBL] [Abstract][Full Text] [Related]
6. Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.
Sheftell FD; Feleppa M; Tepper SJ; Volcy M; Rapoport AM; Bigal ME
Headache; 2004; 44(7):661-8. PubMed ID: 15209687
[TBL] [Abstract][Full Text] [Related]
7. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
Gawel M; Aschoff J; May A; Charlesworth BR;
Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
[TBL] [Abstract][Full Text] [Related]
8. Part III: the convenience of, and patient preference for, zolmitriptan orally disintegrating tablet.
Dowson AJ; Almqvist P
Curr Med Res Opin; 2005; 21 Suppl 3():S13-7. PubMed ID: 16083519
[TBL] [Abstract][Full Text] [Related]
9. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
Chen LC; Ashcroft DM
Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
[TBL] [Abstract][Full Text] [Related]
11. Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy.
Goadsby PJ; Yates R
Headache; 2006 Jan; 46(1):138-49. PubMed ID: 16412161
[TBL] [Abstract][Full Text] [Related]
12. Part IV: effects of zolmitriptan orally disintegrating tablet on migraine symptoms and ability to perform normal activities: a post-marketing surveillance study in Germany.
Diener HC; Gendolla A
Curr Med Res Opin; 2005; 21 Suppl 3():S18-24. PubMed ID: 16083520
[TBL] [Abstract][Full Text] [Related]
13. Zolmitriptan.
Can Fam Physician; 1999 Jun; 45():1491-4, 1497-501. PubMed ID: 10386213
[TBL] [Abstract][Full Text] [Related]
14. Zelrix: a novel transdermal formulation of sumatriptan.
Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
[TBL] [Abstract][Full Text] [Related]
15. Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.
Natarajan S; Jabbour JT; Webster CJ; Richardson MS
Headache; 2004; 44(10):969-77. PubMed ID: 15546259
[TBL] [Abstract][Full Text] [Related]
16. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen.
Evers S; Rahmann A; Kraemer C; Kurlemann G; Debus O; Husstedt IW; Frese A
Neurology; 2006 Aug; 67(3):497-9. PubMed ID: 16775229
[TBL] [Abstract][Full Text] [Related]
17. An open preference study with sumatriptan 50 mg and zolmitriptan 2.5 mg in 100 migraine patients.
Pascual J; Muñoz R; Leira R
Cephalalgia; 2001 Jul; 21(6):680-4. PubMed ID: 11531900
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.
Allais G; Acuto G; Cabarrocas X; Esbri R; Benedetto C; Bussone G
Neurol Sci; 2006 May; 27 Suppl 2():S193-7. PubMed ID: 16688629
[TBL] [Abstract][Full Text] [Related]
19. Rational migraine management: optimising treatment with the triptans.
Millson DS
Funct Neurol; 2000; 15 Suppl 3():182-91. PubMed ID: 11200789
[TBL] [Abstract][Full Text] [Related]
20. Almotriptan and zolmitriptan in the acute treatment of migraine.
Goadsby PJ; Massiou H; Pascual J; Diener HC; Dahlöf CG; Mateos V; Dowson AJ; Raets I; Cunha L; Färkkilä M; Manzoni GC
Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
